Variant report
Variant | esv1001926 |
---|---|
Chromosome Location | chr5:68281457-68292160 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:68285646..68288257-chr5:68336896..68339425,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs571610951 | chr5:68281542-68281543 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs181844535 | chr5:68281543-68281544 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs556933886 | chr5:68281556-68281557 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs567255384 | chr5:68281579-68281580 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs536934553 | chr5:68281583-68281584 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs376518700 | chr5:68281587-68281588 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs555272086 | chr5:68281589-68281590 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs573903611 | chr5:68281600-68281601 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs186442460 | chr5:68281629-68281630 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs536193369 | chr5:68281669-68281670 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs563771817 | chr5:68281673-68281674 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs11463055 | chr5:68281684-68281685 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs563058488 | chr5:68281685-68281686 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs397823780 | chr5:68281693-68281694 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs545163232 | chr5:68281704-68281705 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs563256775 | chr5:68281760-68281761 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs144394320 | chr5:68281796-68281797 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs139308328 | chr5:68281840-68281841 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs142707673 | chr5:68281957-68281958 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs191631627 | chr5:68282005-68282006 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs528791380 | chr5:68282082-68282083 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs147345333 | chr5:68282107-68282108 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs571858053 | chr5:68282151-68282152 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs4976007 | chr5:68282152-68282153 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs550697066 | chr5:68282181-68282182 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs568892445 | chr5:68282215-68282216 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs536220799 | chr5:68282250-68282251 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs374561960 | chr5:68282252-68282253 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs567399055 | chr5:68282271-68282272 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs111826011 | chr5:68282273-68282274 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs552880522 | chr5:68282276-68282277 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs577801741 | chr5:68282285-68282286 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs34515249 | chr5:68282322-68282323 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs545101996 | chr5:68282328-68282329 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs397762406 | chr5:68282333-68282334 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs557064924 | chr5:68282341-68282342 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs4385164 | chr5:68282363-68282364 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs115078778 | chr5:68282385-68282386 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs528492032 | chr5:68282440-68282441 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs560942912 | chr5:68282489-68282490 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs528778242 | chr5:68282520-68282521 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs12657477 | chr5:68282541-68282542 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs565322918 | chr5:68282651-68282652 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs6874774 | chr5:68282671-68282672 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs183462905 | chr5:68282730-68282731 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs61600663 | chr5:68282767-68282768 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs56275714 | chr5:68282846-68282847 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs566896620 | chr5:68282862-68282863 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs534596360 | chr5:68282886-68282887 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs546899735 | chr5:68282913-68282914 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Breast cancer | 22032731 | CNVD |
Prostate cancer | 21965145 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Oral cancer | 21386901 | CNVD |
Bladder cancer | 21909424 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 19602461 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
abnormal development | 18461090 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Breast cancer | 21045282 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Lung cancer | 17086460 | CNVD |
Prostate cancer | 16461572 | CNVD |
Myelodysplastic syndrome | 18663149 | CNVD |
Spinal muscular atrophy | 15981080 | CNVD |
Spinal muscular atrophy | 18839960 | CNVD |
Spinal muscular atrophy | 19716110 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:68281000-68281600 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
2 | chr5:68281000-68281600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
3 | chr5:68281200-68281600 | Enhancers | Right Atrium | heart |
4 | chr5:68281400-68282800 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
5 | chr5:68282800-68283200 | Enhancers | HUES64 Cell Line | embryonic stem cell |
6 | chr5:68286800-68287200 | Enhancers | HSMMtube | muscle |
7 | chr5:68289000-68289200 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
8 | chr5:68289800-68290000 | Enhancers | GM12878-XiMat | blood |
9 | chr5:68290000-68291000 | Flanking Active TSS | GM12878-XiMat | blood |
10 | chr5:68290200-68290400 | Enhancers | Duodenum Smooth Muscle | Duodenum |
11 | chr5:68290200-68290400 | Enhancers | NHEK | skin |
12 | chr5:68290200-68291000 | Enhancers | Fetal Lung | lung |
13 | chr5:68290200-68292000 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
14 | chr5:68290400-68290800 | Enhancers | Brain Inferior Temporal Lobe | brain |
15 | chr5:68290400-68290800 | Flanking Active TSS | NHEK | skin |
16 | chr5:68290400-68292000 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
17 | chr5:68290400-68292000 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
18 | chr5:68290400-68292200 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
19 | chr5:68290600-68292200 | Enhancers | HMEC | breast |
20 | chr5:68290800-68291800 | Enhancers | Primary hematopoietic stem cells | blood |
21 | chr5:68290800-68292000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
22 | chr5:68290800-68292200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
23 | chr5:68290800-68292200 | Enhancers | NHEK | skin |
24 | chr5:68291000-68291800 | Enhancers | GM12878-XiMat | blood |
25 | chr5:68291600-68292200 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
26 | chr5:68292000-68296200 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |